Latest Articles

This article explores how innovative screening methods and AI are advancing therapeutic antibody discovery by improving throughput, reducing bias and enabling deeper insights.

Dr. Magdalena Renne, a leading expert in 3D organoid systems, details how her team has overcome longstanding barriers in retinal organoid production, enabling large-scale drug testing and long-term disease modeling.

Researchers are developing new strategies to drug the undruggable in cancer, including targeting intracellular KRAS with radio-labeled antibodies and using AI and quantum computing to overcome drug resistance.

This article explores how mass spectrometry and emerging analytical techniques are helping researchers decode the aging proteome at multiple scales – from plasma to specific tissues to individual organelles.

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in modern treatments.

Scientists have discovered how two genes control the regeneration of sensory hair cells in zebrafish, a process that fish perform naturally but humans cannot, offering new clues for addressing hearing loss in humans.

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive alternative to traditional methods. However, challenges remain due to the interference of proteins from other organs.

Learn how specific miRNA signatures have potential as metastatic colorectal cancer biomarkers, enhancing non-invasive detection and patient risk stratification.

For this article, Technology Networks asked a diverse group of academics and industry leaders: How should research funding change to better support innovation? Here’s how current models help – or hinder – their work.

Learn about the potential of EEG biomarkers in the early detection and monitoring of neurological diseases such as Alzheimer's with Dr. Javier Escudero, reader in biomedical signal processing at the University of Edinburgh.